Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework

Bioinformatics

Volumn 26, Issue 12, 2010, Pages

  Yamanishi, Yoshihiro ^a,b,c   Kotera, Masaaki ^d   Kanehisa, Minoru ^d,e   Goto, Susumu ^d  

^a PSL RESEARCH UNIVERSITY   (France)

^b INSTITUT CURIE   (France)

^c INSERM U900   (France)

^d KYOTO UNIVERSITY   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; ION CHANNEL; OPIATE RECEPTOR;

ARTICLE; BINDING SITE; CHEMISTRY; DRUG ANTAGONISM; DRUG DEVELOPMENT; DRUG INTERACTION; GENOMICS; METABOLISM; METHODOLOGY;

BINDING SITES; DRUG DISCOVERY; DRUG INTERACTIONS; GENOMICS; ION CHANNELS; PHARMACEUTICAL PREPARATIONS; RECEPTORS, OPIOID;

EID: 77954230951     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btq176     Document Type: Article

References (40)

1. Aronoff, D.M. et al. (2003) Inhibition of prostaglandin h2 synthases by salicylate is dependent on the oxidative state of the enzymes. J. Pharamacol. Exp. Thera., 304, 589-595.
2. Balsinde, J. et al. (1999) Regulation and inhibition of phospholipase. Annu. Rev. Pharmacol. Toxicol., 39, 175-189.
3. Bleakley, K. and Yamanishi, Y. (2009) Supervised prediction of drug-target interactions using bipartite local models. Bioinformatics, 25, 2397-2403.
4. Bluefarb, S.M. et al. (1976) Diflorasone diacetate: vasoconstrictor activity and clinical efficacy of a new topical corticosteroid. J. Int. Med. Res., 4, 454-461.
5. Bock, J.R. and Gough, D.A. (2005) Virtual screen for ligands of orphang protein-coupled receptors. J. Chem. Inf. Model, 45, 1402-1414.
6. Butina, D. et al. (2002) Predicting ADME properties in silico: methods and models. Drug Discov. Today, 7, S83-S88.
7. Byvatov, E. et al. (2003) Comparison of support vector machine and articial neural network systems for drug/nondrug classification. J. Chem. Inf. Comput. Sci., 43, 1882-1889.
8. Campillos, M. et al. (2008) Drug target identification using side-effect similarity. Science, 321, 263-266.
9. +-ATPase or erythrocytes. Br. J. Clin. Pharmacol., 11, 565-570.
10. Darias, V. et al. (2006) Synthesis and preliminary pharmacological study of thiophene analogues of the antipyretic and analgesic agent ethenzamide. Arch. Pharm., 325, 83-87.
11. Dobson, C.M. (2004) Chemical space and biology. Nature, 432, 824-828.
12. Emerit, I. et al. (1983) Suppression of tumor promoter phorbolmyristate acetate-induced chromosome breakage by antioxidants and inhibitors of arachidonic acid metabolism. Mutat. Res., 110, 327-335.
13. Erhan, D. et al. (2006) Collaborative ltering on a family of biological targets. J. Chem. Inf. Model, 46, 626-635.
14. Faulon, J.L et al. (2008) Genome scale enzyme-metabolite and drug-target interaction predictions using the signature molecular descriptor. Bioinformatics, 24, 225-233.
15. Frankl, R. (1953) Intravenous salicylamide therapy in rheumatic diseases. Munch. Med. Wochensch., 95, 512-513.
16. Goto, K. et al. (1998) Analgesic effect of mofezolac, a non-steroidal anti-inflammatory drug, against phenylquinone-induced acute pain in mice. Prostaglandins Other Lipid Mediat., 56, 245-254.
17. Gribskov, M. and Robinson, N.L. (1996) Use of receiver operating characteristic (ROC) analysis to evaluate sequence matching. Comput. Chem., 20, 25-33.
18. Gunther, S. et al. (2008) SuperTarget and Matador: resources for exploring drug-target relationships. Nucleic Acids Res., 36, D919-D922.
19. Hattori, M. et al. (2003) Development of a chemical structure comparison method for integrated analysis of chemical and genomic information in the metabolic pathways. J. Am. Chem. Soc., 125, 11853-11865.
20. Hirano, T. et al. (1995) Citrus flavone tangeretin inhibits leukaemic hl-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes. Br. J. Cancer, 72, 1380-1388.
21. Jacob, L. and Vert, J.-P. (2008) Protein-ligand interaction prediction: an improved chemogenomics approach. Bioinformatics, 24, 2149-2156.
22. Kanehisa, M. et al. (2006) From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res., 34, D354-357.
23. Kanehisa, M. et al. (2008) KEGG for linking genomes to life and the environment. Nucleic Acids Res., 36, D480-D485.
24. Kaufmann, B. et al. (1981) Pharmacokinetics of metildigoxin and digoxin in geriatric patients with normal and elevated serum creatinine levels. Clin. Pharmacokinet., 6, 463-468.
25. Keele.C.A. (1969) Sites and modes of action of antipyretic-analgesic drug. Proc. R. Soc. Med., 62, 535-539.
26. Lodhi, H. and Yamanishi, Y. (2010) Chemoinformatics and Advanced Machine Learning Perspectives: Complex Computational Methods and Collaborative Techniques.IGI Global, Hershey, PA.
27. Nagamine, N. and Sakakibara, Y. (2007) Statistical prediction of protein-chemical interactions based on chemical structure and mass spectrometry data. Bioinformatics, 23, 2004-2012.
28. Preston, S.J. et al. (1989) Comparative analgesic and anti-inflammatory properties of sodium salicylate and acetylsalicylic acid (aspirin) in rheumatoid arthritis. Br. J. Clin. Pharmacol., 27, 607-611.
29. Rarey, M. et al. (1996) A fast flexible docking method using an incremental construction algorithm. J. Mol. Biol., 261, 470-489.
30. Scheiber, J. et al. (2009) Mapping adverse drug reactions in chemical space. J. Med. Chem., 52, 3103-3107.
31. Schlessinger, J. et al. (2006) An open-label adrenal suppression study of 0.1% fluocinonide cream in pediatric patients with atopic dermatitis. Arch. Dermatol., 142, 1568-1572.
32. Schölkopf, B. et al. (2004) Kernel Methods in Computational Biology. MIT Press, Cambridge, MA.
33. Schomburg, I. et al. (2004) BRENDA, the enzyme database: updates and major new developments. Nucleic Acids Res., 32, D431-433.
34. Smith, T.F and Waterman, M.S. (1981) Identification of common molecular subsequences. J. Mol. Biol., 147, 195-197.
35. Stockwell, B.R. (2000) Chemical genetics: ligand-based discovery of gene function. Nat. Rev. Genet., 1, 116-125.
36. Wishart, D.S. et al. (2008) DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res., 36, D901-D906.
37. Yamanishi, Y. (2009) Supervised bipartite graph inference. In Koller, D. et al. (eds), Advances in Neural Information Processing Systems 21, MIT Press, Cambridge, MA, pp. 1841-1848.
38. Yamanishi, Y. et al. (2008) Prediction of drug-target interaction networks from the integration of chemical and genomic spaces. Bioinformatics, 24, i232-i240.
39. Ye, J. et al. (2008) Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis. Int. J. Pharmaceutics, 352, 273-179.
40. Yildirim, M.A. et al. (2007) Drug-target network. Nat. Biotechnol., 25, 1119-1126.